Hypermobile Ehlers-Danlos syndrome (hEDS)

Much of the practical discussion in patient communities is about joints that partly slip out of place (subluxation) rather than fully dislocate. Members swap taping, bracing, and stabilizing techniques, often for subluxations no doctor has confirmed. Clinical literature treats subluxation as close to, but not itself, a diagnostic criterion; the community discussion is about day-to-day management rather than diagnosis.

hEDS, HSD, cEDS · Community knowledge

Members treat finding a physical therapist as a search problem. They share directories and word-of-mouth referrals and look for therapists who avoid the generic exercise programs members consider harmful.

hEDS, HSD · Community knowledge

Members share advice on which specialists diagnose EDS, which tests matter, and how to prepare for an appointment, in response to diagnostic delays that often last years. This is peer advice, not a clinical pathway.

hEDS, HSD · Community knowledge

Patient communities often describe hEDS, POTS (a form of dysautonomia), and mast cell activation syndrome (MCAS) occurring together, and call the combination the “trifecta”. In a Global Registry survey of 505 people with hEDS, POTS and MCAS were among the diagnoses participants most often endorsed as accurate. Whether the three share a mechanism is unknown.

hEDS, HSD · Comorbidities and systemic features

A Global Registry survey of 505 people with clinically confirmed hEDS, published in 2023, found an average of 10.45 other diagnoses. Anxiety, depression, and migraine were the most common. Participants most often rejected functional neurological disorder, multiple sclerosis, and fibromyalgia as wrong, and most often endorsed POTS, cervical instability, and MCAS as accurate.

hEDS · 2023 · Comorbidities and systemic features

Craniocervical instability (CCI) and tethered cord come up often in patient communities, and cervical instability was one of the diagnoses participants most often endorsed as accurate in a Global Registry survey of people with hEDS. Controlled evidence is limited, and surgery for these conditions carries real risk.

hEDS, cEDS · Comorbidities and systemic features

The 2017 series and subsequent cohort work document gastrointestinal dysmotility (reflux, gastroparesis, constipation) and autonomic dysfunction (orthostatic intolerance, POTS) as leading comorbidity domains in hEDS/HSD. In a 2025 survey at a German EDS clinic, musculoskeletal pain and joint instability were the most common first symptoms.

hEDS, HSD · Comorbidities and systemic features

hEDS diagnosis under the 2017 International Classification requires (1) generalized joint hypermobility by Beighton score, (2) two or more of systemic manifestations, positive family history, or musculoskeletal complications, and (3) exclusion of other connective-tissue disorders. Unlike every other subtype, hEDS has no molecular confirmation test.

hEDS, HSD · 2017-03 · Diagnosis and classification

The 2017 framework (Castori et al.) separated symptomatic joint hypermobility into hEDS when the strict criteria are met and HSD when they are not. The boundary is contested. The criteria were designed to define a more uniform group for research, not to declare HSD benign, and the hEDS/HSD criteria review study is ongoing.

HSD, hEDS · 2017-03 · Diagnosis and classification

The Ehlers-Danlos Society says kallikrein (KLK) genes are not on EDS genetic testing panels and that hEDS remains a clinical diagnosis, and that further studies, including the HEDGE study, are needed to replicate the KLK15 finding. The KLK15 authors say their study does not propose a diagnostic framework and that the absence of KLK15 variants should not rule out a clinical diagnosis.

hEDS · 2025-08 · Diagnosis and classification

All twelve other types in the 2017 classification have known causative genes. hEDS, the most common type, has no confirmed molecular basis, so it is diagnosed from clinical criteria alone under the 2017 classification.

hEDS · Genetics

Whole-exome sequencing of 200 people with hEDS by the Norris Lab found rare and low-frequency variants in 14 of the 15 kallikrein (KLK) genes, including a recurrent KLK15 variant (p.Gly226Asp) that segregated in multiple families. Mice carrying the variant showed hEDS features in tendons and heart valves. The Ehlers-Danlos Society says KLK genes are not on EDS genetic testing panels and hEDS remains a clinical diagnosis, and the authors say the study does not propose a diagnostic framework.

hEDS · 2025-08 · Genetics

HEDGE (Hypermobile Ehlers-Danlos Genetic Evaluation), listed among The Ehlers-Danlos Society's research programs, is studying the genetics of 1,000 people with hEDS. In October 2025 the society said it expected the first publications in late 2025 or early 2026, and that timelines may shift.

hEDS, HSD · Genetics

In August 2025 the Norris Lab and colleagues published whole-exome work in iScience implicating kallikrein (KLK) gene variants in hEDS: a recurrent KLK15 variant segregating in multiple families, rare and low-frequency variants in 14 of the 15 KLK genes, and a knock-in mouse with hEDS features in tendons and heart valves. A preprint and The Ehlers-Danlos Society's summary appeared in June 2024. The society says hEDS remains a clinical diagnosis and that replication, including in the HEDGE study, is needed.

hEDS · 2025-08 · Disease historiography

Clinical guidance gives individualized physical therapy (strengthening, proprioceptive work, and pacing) a central role in managing hEDS and HSD. A 2017 paper on physical therapy by Engelbert and colleagues says the research on managing these conditions is limited in size and quality, so the advice rests more on expert consensus and clinical experience than on large trials.

hEDS, HSD · Management and clinical care

Studies of the diagnostic journey in hEDS describe medical gaslighting and post-traumatic stress, and management guidance includes psychological support. A 2025 qualitative study of people with hEDS says physicians should be aware of possible medical post-traumatic stress disorder and highlights the importance of trauma-informed care.

hEDS, HSD · 2025 · Management and clinical care

A qualitative study of people diagnosed with hEDS, published in BMJ Connections Clinical Genetics and Genomics in December 2025, found that experiences with providers ranged from harmful dismissal to validation, and that a diagnosis brought both validation and grief. The authors say physicians who diagnose and treat hEDS should be aware of possible medical post-traumatic stress disorder and past experiences of medical gaslighting. In a separate Global Registry survey of people with hEDS, anxiety and depression were among the most common other diagnoses they had received.

hEDS, HSD · 2025 · Patient experience and diagnostic odyssey

A survey of 99 adults diagnosed at the EDS clinic of University Hospital Cologne, 80 of them with hEDS or HSD, was published in 2025. Musculoskeletal pain and joint instability, including repeated subluxations and dislocations, were the most common first symptoms. Pain was the problem respondents most often said severely affected daily activities (60.2%), followed by joint instability (38.8%), other orthopedic problems (36.7%), digestive complaints (35.7%), and fatigue (32.7%). The results come from one specialist clinic.

hEDS, HSD · 2025 · Patient experience and diagnostic odyssey

In a 2025 survey at a German EDS clinic, 32.7% of respondents said fatigue severely affected their daily activities, after pain, joint instability, other orthopedic problems, and digestive complaints. Fatigue is not one of the 2017 hEDS diagnostic criteria.

hEDS, HSD · Patient experience and diagnostic odyssey